# COVID 19 ANTOBODIES IN PREGNANT WOMEN AND THEIR CONNECTION TO BETA CELL FUNCTION IN THE FETUS

> **NCT04860908** · — · UNKNOWN · sponsor: **Maaynei Hayesha Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Generation of Anti COVID-19 Antibodies in a Fetus, Whose Mother Was Exposed to COVID or Was Vaccinated During Pregnancy

## Interventions

- **OTHER:** no intervention, observation only

## Key facts

- **NCT ID:** NCT04860908
- **Lead sponsor:** Maaynei Hayesha Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-26
- **Primary completion:** 2022-01-01
- **Final completion:** 2022-07-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2021-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04860908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04860908, "COVID 19 ANTOBODIES IN PREGNANT WOMEN AND THEIR CONNECTION TO BETA CELL FUNCTION IN THE FETUS". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04860908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*